Wuxi Biologics Unit’s Hong Kong IPO Closes Order Book Early
Wall Street Journal
A unit of Wuxi Biologics closed its order book a day early for its initial public offering, people familiar with the matter said, a rare instance of hot demand in a choppy year for listings in Hong Kong.